
Press Releases
Relevium Secures North American Exclusivity for Medical Examination Gloves, with First Shipment to Arrive in Los Angeles by Mid April
MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the company has secured delivery of the delivery of first production batch Personal...
read moreRelevium Announces Investor Relations Conference Call
MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to invite all shareholders, partners, affiliates and interested parties to attend a “town hall” Investor...
read moreRelevium Reports Interim First Quarter Results for the Three-Month Period Ended September 30, 2020
MONTREAL, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report the completion of the interim financial statements and MD&A for the three-month period ended...
read moreRelevium Reports Fiscal Year Ended June 30, 2020 Results
MONTREAL, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report the completion of the financial audit for the fiscal year ended June 30, 2020. The Company’s...
read moreRelevium Issues Corporate Update on MCTO and Filing of Financial Statements
MONTREAL, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) announces an update on its ongoing disclosure obligations and to its previously disclosed management cease trade...
read moreRelevium Provides Regulatory Update on Annual Financials and Management Cease Trade Order
MONTREAL, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is providing an update to its previously disclosed management cease trade order ("MCTO"), announced on October 27,...
read moreRelevium Provides Update to Management Cease Trade Order
MONTREAL, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is providing an update to its previously disclosed management cease trade order ("MCTO"), announced on October 27,...
read moreRelevium Announces Delay in Filing Annual Audited Financial Statements
MONTREAL, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) announces that its annual financial statements for the year ended June 30, 2020, including the related management...
read moreRelevium Resumes Shipments for Overseas Contract and Delivers CAD $215,000 in Formulated Products to Saudi Arabia
MONTREAL, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the Company’s subsidiary, BGX E-Health LLC (“BGX”), has shipped a total of CAD...
read moreRelevium’s BGX E-Health Begins Delivery of US$16.9M of Its Initial PPE Contract via Air Freight Charters
MONTREAL, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that its wholly-owned subsidiary in the US, BGX E-Health LLC ( “BGX”), has secured up to...
read moreRelevium’s BGX E-Health Secures US$20M Contract for Supplying PPE to the Canadian Market for Q1 of the Current Fiscal Year
MONTREAL, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that its wholly-owned subsidiary in the US, BGX E-Health LLC ( “BGX”), has secured a USD$20...
read moreRelevium Licenses Patented Science-Based Natural Formulation That Addresses Major Points of Viral Invasion, Replication and Toxicities
MONTREAL, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce it has secured licenced a patented science based nutraceutical formulation that addresses...
read more